PremiumThe FlyActinium’s Actimab-A shows antileukemic activity in AML models Levi & Korsinsky LLP Notifies Shareholders of Actinium Pharmaceuticals, Inc.(ATNM) of a Class Action Lawsuit and an Upcoming Deadline Actinium Pharmaceuticals: Strong Financial Health and Promising Clinical Progress Drive Buy Rating PremiumThe FlyActinium Pharmaceuticals enters supply pact with Eckert & Ziegler Actinium Pharmaceuticals: Promising Clinical Advancements and Strong Financial Outlook Support Buy Rating Actinium Pharma enters research collaboration with Memorial Sloan Kettering PremiumRatingsStrategic Advancements and Promising Trials Justify Buy Rating for Actinium Pharmaceuticals Actinium Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Developments and Strategic Partnerships Is ATNM a Buy, Before Earnings? 
